Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 8 of 8 entries
Sorted by: Best Match Show Resources per page
[Not Available].

Duodecim; laaketieteellinen aikakauskirja

Saarijärvi S, Salminen JK, Aärelä E.
PMID: 16862752
Duodecim. 2006;122(11):1279-80.

No abstract available.

Cite
Saarijärvi S, Salminen JK, Aärelä E. Tunnistamattomat tunteet. [Not Available]. Duodecim. 2006;122(11):1279-80
Saarijärvi, S., Salminen, J. K., & Aärelä, E. (2006). Tunnistamattomat tunteet. [Not Available]. Duodecim; laaketieteellinen aikakauskirja, 122(11), 1279-80.
Saarijärvi, Simo, et al. "Tunnistamattomat tunteet." [Not Available]. Duodecim; laaketieteellinen aikakauskirja vol. 122,11 (2006): 1279-80.
Saarijärvi S, Salminen JK, Aärelä E. Tunnistamattomat tunteet. [Not Available]. Duodecim. 2006;122(11):1279-80. Finnish. PMID: 16862752.
Copy Download .nbib Format: NLM
Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity.

Cancer research

Ketola K, Kaljunen H, Taavitsainen S, Kaarijärvi R, Järvelä E, Rodríguez-Martín B, Haase K, Woodcock DJ, Tubio J, Wedge DC, Nykter M, Bova GS.
PMID: 34348967
Cancer Res. 2021 Oct 01;81(19):4901-4909. doi: 10.1158/0008-5472.CAN-21-0371. Epub 2021 Sep 08.

Treatment-eradicated cancer subclones have been reported in leukemia and have recently been detected in solid tumors. Here we introduce Differential Subclone Eradication and Resistance (DSER) analysis, a method developed to identify molecular targets for improved therapy by direct comparison...

Cite
Ketola K, Kaljunen H, Taavitsainen S, et al. Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer Res. 2021;81(19):4901-4909doi: 10.1158/0008-5472.CAN-21-0371.
Ketola, K., Kaljunen, H., Taavitsainen, S., Kaarijärvi, R., Järvelä, E., Rodríguez-Martín, B., Haase, K., Woodcock, D. J., Tubio, J., Wedge, D. C., Nykter, M., & Bova, G. S. (2021). Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer research, 81(19), 4901-4909. https://doi.org/10.1158/0008-5472.CAN-21-0371
Ketola, Kirsi, et al. "Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity." Cancer research vol. 81,19 (2021): 4901-4909. doi: https://doi.org/10.1158/0008-5472.CAN-21-0371
Ketola K, Kaljunen H, Taavitsainen S, Kaarijärvi R, Järvelä E, Rodríguez-Martín B, Haase K, Woodcock DJ, Tubio J, Wedge DC, Nykter M, Bova GS. Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer Res. 2021 Oct 01;81(19):4901-4909. doi: 10.1158/0008-5472.CAN-21-0371. Epub 2021 Sep 08. PMID: 34348967.
Copy Download .nbib Format: NLM
[Not Available].

Duodecim; laaketieteellinen aikakauskirja

Hautala L, Alin J, Liuksila PR, Räihä H, Saarijärvi S.
PMID: 17115631
Duodecim. 2006;122(17):2137-44.

No abstract available.

Cite
Hautala L, Alin J, Liuksila PR, et al. SCOFF-syömishäiriöseulan reliabiliteetti ja rakennevaliditeetti murrosikäisten koululaisten seulonnassa. [Not Available]. Duodecim. 2006;122(17):2137-44
Hautala, L., Alin, J., Liuksila, P. R., Räihä, H., & Saarijärvi, S. (2006). SCOFF-syömishäiriöseulan reliabiliteetti ja rakennevaliditeetti murrosikäisten koululaisten seulonnassa. [Not Available]. Duodecim; laaketieteellinen aikakauskirja, 122(17), 2137-44.
Hautala, Lea, et al. "SCOFF-syömishäiriöseulan reliabiliteetti ja rakennevaliditeetti murrosikäisten koululaisten seulonnassa." [Not Available]. Duodecim; laaketieteellinen aikakauskirja vol. 122,17 (2006): 2137-44.
Hautala L, Alin J, Liuksila PR, Räihä H, Saarijärvi S. SCOFF-syömishäiriöseulan reliabiliteetti ja rakennevaliditeetti murrosikäisten koululaisten seulonnassa. [Not Available]. Duodecim. 2006;122(17):2137-44. Finnish. PMID: 17115631.
Copy Download .nbib Format: NLM
Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity.

Cancer research

Ketola K, Kaljunen H, Taavitsainen S, Kaarijärvi R, Järvelä E, Rodríguez-Martín B, Haase K, Woodcock DJ, Tubio J, Wedge DC, Nykter M, Bova GS.
PMID: 34348967
Cancer Res. 2021 Oct 01;81(19):4901-4909. doi: 10.1158/0008-5472.CAN-21-0371. Epub 2021 Sep 08.

Treatment-eradicated cancer subclones have been reported in leukemia and have recently been detected in solid tumors. Here we introduce Differential Subclone Eradication and Resistance (DSER) analysis, a method developed to identify molecular targets for improved therapy by direct comparison...

Cite
Ketola K, Kaljunen H, Taavitsainen S, et al. Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer Res. 2021;81(19):4901-4909doi: 10.1158/0008-5472.CAN-21-0371.
Ketola, K., Kaljunen, H., Taavitsainen, S., Kaarijärvi, R., Järvelä, E., Rodríguez-Martín, B., Haase, K., Woodcock, D. J., Tubio, J., Wedge, D. C., Nykter, M., & Bova, G. S. (2021). Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer research, 81(19), 4901-4909. https://doi.org/10.1158/0008-5472.CAN-21-0371
Ketola, Kirsi, et al. "Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity." Cancer research vol. 81,19 (2021): 4901-4909. doi: https://doi.org/10.1158/0008-5472.CAN-21-0371
Ketola K, Kaljunen H, Taavitsainen S, Kaarijärvi R, Järvelä E, Rodríguez-Martín B, Haase K, Woodcock DJ, Tubio J, Wedge DC, Nykter M, Bova GS. Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity. Cancer Res. 2021 Oct 01;81(19):4901-4909. doi: 10.1158/0008-5472.CAN-21-0371. Epub 2021 Sep 08. PMID: 34348967.
Copy Download .nbib Format: NLM
Developing an internet-based support system for adolescents with depression.

JMIR research protocols

Välimäki M, Kurki M, Hätönen H, Koivunen M, Selander M, Saarijärvi S, Anttila M.
PMID: 23612485
JMIR Res Protoc. 2012 Dec 12;1(2):e22. doi: 10.2196/resprot.2263.

BACKGROUND: Depression is the most common mental health problem among adolescents. Despite policy guidance and governmental support to develop usable mental health services, there is still a lack of easily accessible and modern interventions available for adolescents in Finland's...

Cite
Välimäki M, Kurki M, Hätönen H, et al. Developing an internet-based support system for adolescents with depression. JMIR Res Protoc. 2012;1(2):e22doi: 10.2196/resprot.2263.
Välimäki, M., Kurki, M., Hätönen, H., Koivunen, M., Selander, M., Saarijärvi, S., & Anttila, M. (2012). Developing an internet-based support system for adolescents with depression. JMIR research protocols, 1(2), e22. https://doi.org/10.2196/resprot.2263
Välimäki, Maritta, et al. "Developing an internet-based support system for adolescents with depression." JMIR research protocols vol. 1,2 (2012): e22. doi: https://doi.org/10.2196/resprot.2263
Välimäki M, Kurki M, Hätönen H, Koivunen M, Selander M, Saarijärvi S, Anttila M. Developing an internet-based support system for adolescents with depression. JMIR Res Protoc. 2012 Dec 12;1(2):e22. doi: 10.2196/resprot.2263. PMID: 23612485; PMCID: PMC3626154.
Copy Download .nbib Format: NLM
Development of alexithymic personality features.

World journal of psychiatry

Karukivi M, Saarijärvi S.
PMID: 25540724
World J Psychiatry. 2014 Dec 22;4(4):91-102. doi: 10.5498/wjp.v4.i4.91.

The purpose of this paper is to review the current literature regarding the development of alexithymic personality features. Modern brain imaging technologies provide interesting data on the associations of alexithymia with different aberrations in brain function related to emotion...

Cite
Karukivi M, Saarijärvi S. Development of alexithymic personality features. World J Psychiatry. 2014;4(4):91-102doi: 10.5498/wjp.v4.i4.91.
Karukivi, M., & Saarijärvi, S. (2014). Development of alexithymic personality features. World journal of psychiatry, 4(4), 91-102. https://doi.org/10.5498/wjp.v4.i4.91
Karukivi, Max, and Saarijärvi, Simo. "Development of alexithymic personality features." World journal of psychiatry vol. 4,4 (2014): 91-102. doi: https://doi.org/10.5498/wjp.v4.i4.91
Karukivi M, Saarijärvi S. Development of alexithymic personality features. World J Psychiatry. 2014 Dec 22;4(4):91-102. doi: 10.5498/wjp.v4.i4.91. PMID: 25540724; PMCID: PMC4274591.
Copy Download .nbib Format: NLM
Large-scale loyalty card data in health research.

Digital health

Nevalainen J, Erkkola M, Saarijärvi H, Näppilä T, Fogelholm M.
PMID: 30546912
Digit Health. 2018 Nov 29;4:2055207618816898. doi: 10.1177/2055207618816898. eCollection 2018.

OBJECTIVE: To study the characteristics of large-scale loyalty card data obtained in Finland, and to evaluate their potential and challenges in health research.METHODS: We contacted the holders of a certain loyalty card living in a specific region in Finland...

Cite
Nevalainen J, Erkkola M, Saarijärvi H, et al. Large-scale loyalty card data in health research. Digit Health. 2018;4:2055207618816898doi: 10.1177/2055207618816898.
Nevalainen, J., Erkkola, M., Saarijärvi, H., Näppilä, T., & Fogelholm, M. (2018). Large-scale loyalty card data in health research. Digital health, 42055207618816898. https://doi.org/10.1177/2055207618816898
Nevalainen, Jaakko, et al. "Large-scale loyalty card data in health research." Digital health vol. 4 (2018): 2055207618816898. doi: https://doi.org/10.1177/2055207618816898
Nevalainen J, Erkkola M, Saarijärvi H, Näppilä T, Fogelholm M. Large-scale loyalty card data in health research. Digit Health. 2018 Nov 29;4:2055207618816898. doi: 10.1177/2055207618816898. eCollection 2018. PMID: 30546912; PMCID: PMC6287323.
Copy Download .nbib Format: NLM
Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression.

Cancers

Kaarijärvi R, Kaljunen H, Ketola K.
PMID: 33572108
Cancers (Basel). 2021 Feb 09;13(4). doi: 10.3390/cancers13040692.

Neuroendocrine plasticity and treatment-induced neuroendocrine phenotypes have recently been proposed as important resistance mechanisms underlying prostate cancer progression. Treatment-induced neuroendocrine prostate cancer (t-NEPC) is highly aggressive subtype of castration-resistant prostate cancer which develops for one fifth of patients under...

Cite
Kaarijärvi R, Kaljunen H, Ketola K. Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression. Cancers (Basel). 2021;13(4)doi: 10.3390/cancers13040692.
Kaarijärvi, R., Kaljunen, H., & Ketola, K. (2021). Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression. Cancers, 13(4), . https://doi.org/10.3390/cancers13040692
Kaarijärvi, Roosa, et al. "Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression." Cancers vol. 13,4 (2021). doi: https://doi.org/10.3390/cancers13040692
Kaarijärvi R, Kaljunen H, Ketola K. Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression. Cancers (Basel). 2021 Feb 09;13(4). doi: 10.3390/cancers13040692. PMID: 33572108; PMCID: PMC7915380.
Copy Download .nbib Format: NLM
Showing 1 to 8 of 8 entries